NCT00040209View on ClinicalTrials.gov

JP-1730 to Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

July 31, 2005

Conditions
Parkinson Disease
Interventions
DRUG

JP 1730

DRUG

IV Levodopa

DRUG

IV Apomorphine

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00040209 - JP-1730 to Treat Parkinson's Disease | Biotech Hunter | Biotech Hunter